LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Diprivan® (propofol) injectable emulsion in 10 mL single patient infusion vials. Diprivan is an intravenous sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation and is one of the most widely used anesthesia products in the United States. Fresenius Kabi is a global health care company that specializes in life-saving medicines and technologies for infusion, transfusion and clinical nutrition.
Help employers find you! Check out all the jobs and post your resume.
